David A Gershon
Medical Practice in New York, NY
License number
New Jersey 25MA06553200
Issued Date
Apr 28, 1997
Expiration Date
Jun 30, 2003
Category
Medical Examiners
Type
Medical Doctor
Address
Address
New York, NY
Personal information
See more information about David A Gershon at radaris.comName
Address
Phone
40 Littleworth Ln, Sea Cliff, NY 11579
84 Fairview Pl, Sea Cliff, NY 11579
11817 Union Tpke APT 2A, Forest Hills, NY 11375
300 W 108Th St APT 5A, New York, NY 10025
225 E 70Th St APT 2C, New York, NY 10021
Professional information
Consultant On Social And Organizational Transformation To Corporations, Government Agencies And Non Profits
Location:
Greater New York City Area
Industry:
Professional Training & Coaching
Skills:
Sustainability, Coaching, Personal Development, Organizational Development, Sustainable Business, Sustainability Strategy, Sustainability Consulting, Community Organizing, Public Speaking, Leadership Development, Corporate Social Responsibility, Non-profits, Community Outreach, Management Consulting, Fundraising, Business Strategy, Mentoring, Instructional Design, Creative Problem Solving, Workshop Facilitation
Consultant On Social And Organizational Transformation To Corporations, Government Agencies And Non Profits
Location:
Greater New York City Area
Industry:
Professional Training & Coaching
Skills:
Sustainability, Coaching, Personal Development, Organizational Development, Sustainable Business, Sustainability Strategy, Sustainability Consulting, Community Organizing, Public Speaking, Leadership Development, Corporate Social Responsibility, Non-profits, Community Outreach, Management Consulting, Fundraising, Business Strategy, Mentoring, Instructional Design, Creative Problem Solving, Workshop Facilitation, Nonprofits, Entrepreneurship, Sustainable Development, Leadership, Training, Change Management, Program Management
Chief Science Officer And Svp At Redox Pharmaceutical Corp.
Position:
Chief Science Officer and SVP at Redox Pharmaceutical Corp.
Location:
Greater New York City Area
Industry:
Pharmaceuticals
Work:
Redox Pharmaceutical Corp.
-
Chief Science Officer and SVP
David Gershon
Location:
Greater New York City Area
Industry:
Information Technology and Services
Dr. David Gershon, New York NY - MD (Doctor of Medicine)
Specialties:
Neurology
Address:
215 E 68Th St, New York 10065
Languages:
English
Education:
Medical School
McGill University / Faculty of Medicine
McGill University / Faculty of Medicine
David Gershon, New York NY
Specialties:
Oncologist
Address:
215 E 68Th St, New York, NY 10065
Topical Antiviral Therapeutic And Prophylactic Treatment Of Adenoviruses And Their Associated Diseases
US Patent:
2005003, Feb 10, 2005
Filed:
Jun 30, 2004
Appl. No.:
10/883406
Inventors:
David Gershon - New York NY, US
International Classification:
A61K031/7072, A61K031/513
US Classification:
514049000, 514269000
Abstract:
A method for the therapeutic and prophylactic treatment of adeviruses, More specifically, a method for the therapeutic treatment of adenovirus in a subject by topically administering an antiviral effective amount of CTC-96 to the subject. In addition, a method for the prophylactic treatment against an adenovirus infection in a subject by topically administering a prophylactically anti-adenovirus effective amount of CTC-96 to the subject to minimize the likelihood of the subject veing infected by the adenovirus.
Topical Antiviral Therapeutic And Prophylactic Treatment Of Adenoviruses And Their Associated Diseases
US Patent:
2006002, Feb 2, 2006
Filed:
Mar 31, 2005
Appl. No.:
11/097081
Inventors:
David Gershon - New York NY, US
International Classification:
A61L 9/04, A61K 31/555
US Classification:
514184000, 424045000
Abstract:
A method for the therapeutic and prophylactic treatment of adeviruses, More specifically, a method for the therapeutic treatment of adenovirus in a subject by topically administering an antiviral effective amount of CTC-96 to the subject. In addition, a method for the prophylactic treatment against an adenovirus infection in a subject by topically administering a prophylactically anti-adenovirus effective amount of CTC-96 to the subject to minimize the likelihood of the subject veing infected by the adenovirus.
Microbicidal, Prophylactic And Therapeutic Effect Of Ctc-96 On Papilloma Viruses
US Patent:
2007014, Jun 21, 2007
Filed:
Jun 21, 2004
Appl. No.:
10/561323
Inventors:
David Gershon - New York NY, US
Assignee:
REDOX PHARMACEUTICAL CORPORATION, AUDUBON BIOMEDICAL SCIENCE AND TECHNOLOGY PACK - NEW YORK NY
International Classification:
A61K 31/555
US Classification:
514184000
Abstract:
A method for the therapeutic and prophylactic treatment of subjects infected with the papilloma virus. More specifically, a method of therapeutic treatment of a papilloma virus in a subject by administering an anti-papilloma virus effective amount of CTC-96 to the subject. In addition, a method of prophylactic treatment against a papilloma virus in a subject by administering an anti-papilloma virus effective amount of CTC-96 to the subject to minimize the likelihood of the subject being infected by the papolloma virus.
Method And Composition For Treatment Of Tumors
US Patent:
2013011, May 9, 2013
Filed:
Jul 8, 2011
Appl. No.:
13/808793
Inventors:
David Gershon - New York NY, US
International Classification:
A61K 31/555
US Classification:
514184
Abstract:
A method for ameliorating tumors which result from high or increased activity of Gli by treating a human subject evidencing tumor growth by treating the subject with a deactivating effective amount of CTC-96 to reduce or inhibit tumor growth.